Vědecké studie o Tea Tree oleji

Abe, S., N. Maruyama, K. Hayama, H. Ishibashi, S. Inoue, H. Oshima, and H. Yamaguchi. 2003. Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. Med. Inflamm. 12:323–328.

Altman, P. M. 1988. Australian tea tree oil. Aust. J. Pharm. 69:276–278.

Andrews, R. E., L. W. Parks, and K. D. Spence. 1980. Some effects of
Douglas fir terpenes on certain microorganisms. Appl. Environ. Microbiol. 40:301–304.

Anonymous 1933. An Australian antiseptic oil. Br. Med. J. i:966.

Anonymous. 1930. A retrospect. Med. J. Aust. i:85–89.

Anonymous. 1933. Ti-trol oil. Br. Med. J. ii:927.

Ånse´hn, S. 1990. The effect of tea tree oil on human pathogenic bacteria and fungi in a laboratory study. Swed. J. Biol. Med. 2:5–8.

Arweiler, N. B., N. Donos, L. Netuschil, E. Reich, and A. Sculean. 2000. Clinical and antibacterial effect of tea tree oil—a pilot study. Clin. Oral Investig. 4:70–73.

Aspres, N., and S. Freeman. 2003. Predictive testing for irritancy and allergenicity of tea tree oil in normal human subjects. Exogenous Dermatol. 2:258–261.

Atkinson, N., and H. E. Brice. 1955. Antibacterial substances produced by flowering plants. Australas. J. Exp. Biol. 33:547–554.

Baker, G. 1999. Tea tree breeding, p. 135–154. In I. Southwell and R. Lowe (ed.), Tea tree: the genus Melaleuca, vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.

Banes-Marshall, L., P. Cawley, and C. A. Phillips. 2001. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. iso-lates from clinical specimens. Br. J. Biomed. Sci. 58:139–145.

Bassett, I. B., D. L. Pannowitz, and R. S. Barnetson. 1990. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med.J. Aust. 153:455–458.

Beylier, M. F. 1979. Bacteriostatic activity of some Australian essential oils. Perfum. Flavourist 4:23–25.

Biju, S. S., A. Ahuja, R. K. Khar, and R. Chaudhry. 2005. Formulation and evaluation of an effective pH balanced topical antimicrobial product containing tea tree oil. Pharmazie 60:208–211.

Bischoff, K., and F. Guale. 1998. Australian tea tree (Melaleuca alternifolia) oil poisoning in three purebred cats. J. Vet. Diagn. Investig. 10:208–210.

Bishop, C. D. 1995. Antiviral activity of the essential oil of Melaleucaalternifolia (Maiden & Betche) Cheel (tea tree) against tobacco mosaic virus. J. Essent. Oil Res. 7:641–644.

Blackwell, A. L. 1991. Tea tree oil and anaerobic (bacterial) vaginosis.Lancet 337:300.

Blackwell, R. 1991. An insight into aromatic oils: lavender and tea tree. Br. J. Phytother. 2:26–30.

Bourne, K. Z., N. Bourne, S. F. Reising, and L. R. Stanberry. 1999. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Res. 42:219–226.

Brand, C., A. Ferrante, R. H. Prager, T. V. Riley, C. F. Carson, J. J.
Finlay-Jones, and P. H. Hart. 2001. The water soluble-components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm. Res. 50:213–219.Brand, C., M. A. Grimbaldeston, J. R. Gamble, J. Drew, J. J. Finlay-Jones,
and P. H. Hart. 2002. Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm. Res. 51:236–244.

Brand, C., S. L. Townley, J. J. Finlay-Jones, and P. H. Hart. 2002. Tea tree oil reduces histamine-induced oedema in murine ears. Inflamm. Res. 51:283–289.

Brophy, J. J., N. W. Davies, I. A. Southwell, I. A. Stiff, and L. R. Williams.Gas chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). J. Agric. Food Chem. 37:1330–1335.

Buck, D. S., D. M. Nidorf, and J. G. Addino. 1994. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J. Fam. Pract. 38:601–605.

Caboi, F., S. Murgia, M. Monduzzi, and P. Lazzari. 2002. NMR investigation on Melaleuca alternifolia essential oil dispersed in the monoolein aquous system: phase behavior and dynamics. Langmuir 18:7916–7922.

Caelli, M., J. Porteous, C. F. Carson, R. Heller, and T. V. Riley. 2000. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 46:236–237.

Caldefie-Che´zet, F., M. Guerry, J. C. Chalchat, C. Fusillier, M. P. Vasson, and J. Guillot. 2004. Anti-inflammatory effects of Melaleuca alternifolia essential oil on human polymorphonuclear neutrophils and monocytes. Free Rad. Res. 38:805–811.

Carson, C. F., L. Ashton, L. Dry, D. W. Smith, and T. V. Riley. 2001. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J. Antimicrob. Chemother. 48:450–451.

Carson, C. F., B. D. Cookson, H. D. Farrelly, and T. V. Riley. 1995. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J. Antimicrob. Chemother. 35:421–424.

Carson, C. F., K. A. Hammer, and T. V. Riley. 1995. Broth micro-dilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil).Microbios 82:181–185.

Carson, C. F., K. A. Hammer, and T. V. Riley. 1996. In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp. J. Antimi-crob. Chemother. 37:1177–1178.

Carson, C. F., B. J. Mee, and T. V. Riley. 2002. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob. Agents Chemother. 48:1914–1920.

Carson, C. F., and T. V. Riley. 1993. Antimicrobial activity of the essential loil of Melaleuca alternifolia. Lett. Appl. Microbiol. 16:49–55.

Carson, C. F., and T. V. Riley. 1995. Antimicrobial activity of the major
components of the essential oil of Melaleuca alternifolia. J. Appl. Bacteriol. 78:264–269.

Carson, C. F., and T. V. Riley. 1994. Susceptibility of Propionibacterium acnes to the essential oil of Melaleuca alternifolia. Lett. Appl. Microbiol. 19:24–25.

Cassella, S., J. P. Cassella, and I. Smith. 2002. Synergistic antifungal activity of tea tree (Melaleuca alternifolia) and lavender (Lavandula angus-tifolia) essential oils against dermatophyte infection. Int. J. Aromather. 12:2–15.

Chan, C. H., and K. W. Loudon. 1998. Activity of tea tree oil on methicillin-resistant Staphylococcus aureus (MRSA). J. Hosp. Infect. 39:244–245.

Chand, S., I. Lusunzi, D. A. Veal, L. R. Williams, and P. Caruso. 1994. Rapid screening of the antimicrobial activity of extracts and natural prod-ucts. J. Antibiot. 47:1295–1304.

Chao, S. C., D. G. Young, and C. J. Oberg. 2000. Screening for inhibitory activity of essential oils on selected bacteria, fungi and viruses. J. Essent. Oil Res. 12:639–649.

Christoph, F., P. M. Kaulfers, and E. Stahl-Biskup. 2000. A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with speciál reference to the activity of -triketones. Planta Med. 66:556–560.

Christoph, F., P. M. Kaulfers, and E. Stahl-Biskup. 2001. In vitro evalua-
tion of the antibacterial activity of -triketones admixed to Melaleuca oils. Planta Med. 67:768–771.

Christoph, F., E. Stahl-Biskup, and P. M. Kaulfers. 2001. Death kinetics of Staphylococcus aureus exposed to commercial tea tree oils s.l. J. Essent. Oil Res. 13:98–102.

Colton, R. T., and G. J. Murtagh. 1999. Cultivation of tea tree, p. 63–78. In I. Southwell and R. Lowe (ed.), Tea tree: the genus Melaleuca, vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.

Cotmore, J. M., A. Burke, N. H. Lee, and I. M. Shapiro. 1979. Respiratory inhibition of isolated rat liver mitochondria by eugenol. Arch. Oral Biol. 24:565–568.

Cox, S. D., J. E. Gustafson, C. M. Mann, J. L. Markham, Y. C. Liew, R. P. Hartland, H. C. Bell, J. R. Warmington, and S. G. Wyllie. 1998. Tea tree oil

Cox, S. D., C. M. Mann, and J. L. Markham. 2001. Interactions between components of the essential oil of Melaleuca alternifolia. J. Appl. Microbiol.
91:492–497.

Cox, S. D., C. M. Mann, J. L. Markham, H. C. Bell, J. E. Gustafson, J. R. Warmington, and S. G. Wyllie. 2000. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J. Appl. Microbiol. 88:170–175.

Cox, S. D., C. M. Mann, J. L. Markham, J. E. Gustafson, J. R. Warmington,and S. G. Wyllie. 2001. Determining the antimicrobial actions of tea tree oil. Molecules 6:87–91.

Craven, L. A. 1999. Behind the names: the botany of tea tree, cajuput and niaouli, p. 11–28. In I. Southwell and R. Lowe (ed.), Tea tree: the genus Melaleuca, vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.

D’Auria, F. D., L. Laino, V. Strippoli, M. Tecca, G. Salvatore, L. Battinelli, and G. Mazzanti. 2001. In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J. Chemother. 13:377–383.

Davis, A., J. O’Leary, A. Muthaiyan, M. Langevin, A. Delgado, A. Abalos,
A. Fajardo, J. Marek, B. Wilkinson, and J. Gustafson. 2005. Characterization of Staphylococcus aureus mutants expressing reduced susceptibility to common house-cleaners. J. Appl. Microbiol. 98:364–372.

De Groot, A. C., and J. W. Weyland. 1992. Systemic contact dermatitis from tea tree oil. Contact Dermatitis 27:279–280.

Del Beccaro, M. A. 1995. Melaleuca oil poisoning in a 17-month-old. Vet. Hum. Toxicol. 37:557–558.

Dryden, M. S., S. Dailly, and M. Crouch. 2004. A randomized, control led trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J. Hosp. Infect. 56:283–286.

Elliott, C. 1993. Tea tree oil poisoning. Med. J. Aust. 159:830–831.

Elsom, G. K. F., and D. Hide. 1999. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J. Antimicrob. Chemother. 43:427–428.

Ergin, A., and S. Arikan. 2002. Comparison of microdilution and disc diffusion methods in assessing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. J. Chemother. 14:465–472.

Feinblatt, H. M. 1960. Cajeput-type oil for the treatment of furunculosis. J. Natl. Med. Assoc. 52:32–34.

Griffin, S. G., J. L. Markham, and D. N. Leach. 2000. An agar dilution method for the determination of the minimum inhibitory concentration of essential oils. J. Essent. Oil Res. 12:249–255.

Griffin, S. G., S. G. Wyllie, and J. L. Markham. 1999. Determination of octanol-water partition coefficients for terpenoids using reversed-phase high-perfrormance liquid chromatography. J. Chromatogr. A 864:221–228.

Griffin, S. G., S. G. Wyllie, J. L. Markham, and D. N. Leach. 1999. The role of structure and molecular properties of terpenoids in determining their antimicrobial activity. Flav. Fragr. J. 14:322–332.

Groppo, F. C., J. C. Ramacciato, R. P. Simoes, F. M. Florio, and A. Sartoratto. 2002. Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms. Int. Dent. J. 52:433–437.

Guenther, E. 1968. Australian tea tree oils. Report of a field survey. Perfum. Essent. Oil Rec. 59:642–644.

Gustafson, J. E., S. D. Cox, Y. C. Liew, S. G. Wyllie, and J. R. Warmington.The bacterial multiple antibiotic resistant (Mar) phenotype leads to increased tolerance to tea tree oil. Pathology 33:211–215.

Gustafson, J. E., Y. C. Liew, S. Chew, J. Markham, H. C. Bell, S. G. Wyllie, and J. R. Warmington. 1998. Effects of tea tree oil on Escherichia coli. Lett. Appl. Microbiol. 26:194–198.

Hada, T., S. Furuse, Y. Matsumoto, H. Hamashima, K. Masuda, K. Shiojima, T. Arai, and M. Sasatsu. 2001. Comparison of the effects in vitro of tea tree oil and plaunotol on methicillin-susceptible and methicillin resistant strains of Staphylococcus aureus. Microbios 106(Suppl.2):133–141.

Hada, T., Y. Inoue, A. Shiraishi, and H. Hamashima. 2003. Leakage of K
ions from Staphylococcus aureus in response to tea tree oil. J. Microbiol. Methods 53:309–312.

Halford, A. C. F. 1936. Diabetic gangrene. Med. J. Aust. ii:121–122.

Hammer, K. A., C. F. Carson, and T. V. Riley. 2003. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J. Appl. Microbiol. 95:853–860.

Hammer, K. A., C. F. Carson, and T. V. Riley. 2004. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J. Antimicrob. Chemother. 53:1081–1085.

Hammer, K. A., C. F. Carson, and T. V. Riley. 2000. In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob. Agents Chemother. 44:467–469.

Hammer, K. A., C. F. Carson, and T. V. Riley. 2002. In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J. Antimicrob. Chemother. 50:195–199

Hammer, K. A., C. F. Carson, and T. V. Riley. 1999. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob. Agents Chemother. 43:196.Hammer, K. A., C. F. Carson, and T. V. Riley. 1999. Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro. J. Appl. Microbiol. 86:446–452.

Hammer, K. A., C. F. Carson, and T. V. Riley. 1998. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J. Antimicrob. Chemother. 42:591–595.

Hammer, K. A., C. F. Carson, and T. V. Riley. 2000. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med. Mycol. 38:355–362.

Hammer, K. A., C. F. Carson, and T. V. Riley. 1996. Susceptibility of
transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am. J. Infect. Control 24:186–189.

Hammer, K. A., L. Dry, M. Johnson, E. M. Michalak, C. F. Carson, and T. V. Riley. 2003. Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro. Oral Microbiol. Immunol. 18:389–392.

Hart, P. H., C. Brand, C. F. Carson, T. V. Riley, R. H. Prager, and J. J. Finlay-Jones. 2000. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm. Res. 49:619–626.

Hausen, B. M., J. Reichling, and M. Harkenthal. 1999. Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Am. J. Contact Dermatitis 10:68–77.

Homer, L. E., D. N. Leach, D. Lea, L. S. Lee, R. J. Henry, and P. R. Baverstock. 2000. Natural variation in the essential oil content of Melaleuca alternifolia Cheel (Myrtaceae). Biochem. Syst. Ecol. 28:367–382.

Humphery, E. M. 1930. A new Australian germicide. Med. J. Aust. 1:417–418.

Inouye, S., T. Takizawa, and H. Yamaguchi. 2001. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J. Antimicrob. Chemother. 47:565–573.

Inouye, S., T. Tsuruoka, M. Watanabe, K. Takeo, M. Akao, Y. Nishiyama, and H. Yamaguchi. 2000. Inhibitory effect of essential oils on apical growth of Aspergillus fumigatus by vapour contact. Mycoses 43:17–23.

Inouye, S., K. Uchida, and H. Yamaguchi. 2001. In-vitro and in-vivo anti Trichophyton activity of essential oils by vapour contact. Mycoses 44:99–107.

Inouye, S., M. Watanabe, Y. Nishiyama, K. Takeo, M. Akao, and H. Yamaguchi. 1998. Antisporulating and respiration-inhibitory effects ofessential oils on filamentous fungi. Mycoses 41:403–410.

International Organisation for Standardisation. 2004. ISO 4730:2004. Oil of Melaleuca, terpinen-4-ol type (tea tree oil). International Organisation for Standardisation, Geneva, Switzerland.

Jackson, R. W., and J. A. DeMoss. 1965. Effects of toluene on Escherichia coli. J. Bacteriol. 90:1420–1424.

Jacobs, M. R., and C. S. Hornfeldt. 1994. Melaleuca oil poisoning. J. Toxicol. Clin. Toxicol. 32:461–464.

Jandourek, A., J. K. Vaishampayan, and J. A. Vazquez. 1998. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 12:1033–1037.

Johns, M. R., J. E. Johns, and V. Rudolph. 1992. Steam distillation of tea tree (Melaleuca alternifolia) oil. J. Sci. Food Agric. 58:49–53.

Khalil, Z., A. L Pearce, N. Satkunanathan, E. Storer, J. J. Finlay-Jones, and P. Hart. 2004. Regulation of wheal and flare by tea tree oil: complementary human and rodent studies. J. Investig. Dermatol. 123:683–690.

Klimmek, J. K., R. Nowicki, K. Szendzielorz, M. Kunicka, R. Rosentrit, G. Honisz, and W. Krol. 2002. Application of a tea tree oil and its preparations in combined treatment of dermatomycoses. Mikol. Lekarska 9:93–96.

Knight, T. E., and B. M. Hausen. 1994. Melaleuca oil (tea tree oil) dermatitis. J. Am. Acad. Dermatol. 30:423–427.

Koh, K. J., A. L. Pearce, G. Marshman, J. J. Finlay-Jones, and P. H. Hart.

Tea tree oil reduces histamine-induced skin inflammation. Br. J. Dermatol. 147:1212–1217.

Lassak, E. V., and T. McCarthy. 1983. Australian medicinal plants, p. 93–99, 115. Methuen Australia, North Ryde, Australia.

Longbottom, C. J., C. F. Carson, K. A. Hammer, B. J. Mee, and T. V. Riley.Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes. J. Antimicrob. Chemother. 54:386–392.

Low, D., B. D. Rawal, and W. J. Griffin. 1974. Antibacterial action of the essential oils of some Australian Myrtaceae with special references to theactivity of chromatographic fractions of oil of Eucalyptus citriodora. Planta Med. 26:184–189.

Low, T. 1990. Bush medicine. Harper Collins Publishers, North Ryde, NSW, Australia.

MacDonald, V. 1930. The rationale of treatment. Aust. J. Dent. 34:281–285.

Mann, C. M., S. D. Cox, and J. L. Markham. 2000. The outer membrane of Pseudomonas aeruginosa NCTC 6749 contributes to its tolerance to the essential oil of Melaleuca alternifolia (tea tree oil). Lett. Appl. Microbiol. 30:294–297.

Mann, C. M., and J. L. Markham. 1998. A new method for determining the minimum inhibitory concentration of essential oils. J. Appl. Microbiol 84:538–544.Maruzzella, J. C., and N. A. Sicurella. 1960. Antibacterial activity of essential oil vapors. J. Am. Pharm. Assoc. 49:692–694.

May, J., C. H. Chan, A. King, L. Williams, and G. L. French. 2000. Time-kill studies of tea tree oils on clinical isolates. J. Antimicrob. Chemother. 45:639–643.

Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005. Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests. J. Hosp. Infect. 59:113–125.

Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005. Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499. J. Hosp. Infect. 59:220–228.

Mikus, J., M. Harkenthal, D. Steverding, and J. Reichling. 2000. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med. 66:366–368.

Minami, M., M. Kita, T. Nakaya, T. Yamamoto, H. Kuriyama, and J. Imanishi. 2003. The inhibitory effect of essential oils on herpes simplex virus type-1 replication in vitro. Microbiol. Immunol. 47:681–684.

Mondello, F., F. De Bernardis, A. Girolamo, G. Salvatore, and A. Cassone.In vitro and in vivo activity of tea tree oil against azole-susceptible and resistant human pathogenic yeasts. J. Antimicrob. Chemother. 51:1223–1229.

Morris, M. C., A. Donoghue, J. A. Markowitz, and K. C. Osterhoudt. 2003. Ingestion of tea tree oil (Melaleuca oil) by a 4-year-old boy. Pediatr. Emerg.Care 19:169–171.

Murtagh, J. G. 1999. Biomass and oil production of tea tree, p. 109–133. In I. Southwell and R. Lowe (ed.), Tea tree: the genus Melaleuca, vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.

Nelson, R. R. S. 2000. Selection of resistance to the essential oil of Melaleuca alternifolia in Staphylococcus aureus. J. Antimicrob. Chemother. 45:549–550.

Nelson, R. R. S. 1997. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 40:305–306.

Nenoff, P., U.-F. Haustein, and W. Brandt. 1996. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol. 9:388–394.

Oliva, B., E. Piccirilli, T. Ceddia, E. Pontieri, P. Aureli, and A. Ferrini.Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett. Appl. Microbiol. 37:185–187.

Opdyke, D. L. J. 1975. Fragrance raw materials monographs (eucalyptol).Food Cosmet. Toxicol. 13:105–106.

Pearce, A., J. J. Finlay-Jones, and P. H. Hart. 2005. Reduction of nickel induced contact hypersensitivity reactions by topical tea tree oil in human. Inflamm. Res. 54:22–30.

Pen˜a, E. F. 1962. Melaleuca alternifolia oil—its use for trichomonal vaginitis and other vaginal infections. Obstet. Gynecol. 19:793–795.

Penfold, A. R., and R. Grant. 1925. The germicidal values of some Australian essential oils and their pure constituents, together with those for some essential oil isolates, and synthetics. Part III. J. R. Soc. New South Wales 59:346–349.

Penfold, A. R., and R. Grant. 1923. The germicidal values of the principal commercial Eucalyptus oils and their pure constituents, with observations on the value of concentrated disinfectants. J. R. Soc. New South Wales 57:80–89.

Penfold, A. R., and R. Grant. 1924. The germicidal values of the pure constituents of Australian essential oils, together with those for some essential oil isolates and synthetics. Part II. J. R. Soc. New South Wales 58:117–123.

Penfold, A. R., and F. R. Morrison. 1946. Bulletin no. 14. Australian tea trees of economic value, part 1, 3rd ed. Thomas Henry Tennant, Government Printer, Sydney, Australia.

Perry, N. B., N. J. Brennan, J. W. Van Klink, W. Harris, M. H. Douglas, J. A. McGimpsey, B. M. Smallfield, and A. R. E. 1997. Essential oils from New Zealand manuka and kanuka: chemotaxonomy of Leptospermum. Phytochemistry 44:1485–1494.

Raman, A., U. Weir, and S. F. Bloomfield. 1995. Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Lett. Appl. Microbiol. 21:242–245.

Reichling, J., A. Weseler, U. Landvatter, and R. Saller. 2002. Bioactive essential oils used in phytomedicine as antiinfective agents: Australian tea tree oil and manuka oil. Acta Phytotherapeutica 1:26–32.

Rushton, R. T., N. W. Davis, J. C. Page, and C. A. Durkin. 1997. The effect of tea tree oil extract on the growth of fungi. Lower Extremity 4:113–116.

Russell, M. 1999. Toxicology of tea tree oil, p. 191–201. In I. Southwell an R. Lowe (ed.), Tea tree: the genus Melaleuca, vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.

Satchell, A. C., A. Saurajen, C. Bell, and R. S. Barnetson. 2002. Treatment of dandruff with 5% tea tree oil shampoo. J. Am. Acad. Dermatol. 47:852– 855.Satchell, A. C., A. Saurajen, C. Bell, and R. S. Barnetson. 2002. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo controlled, blinded study. Australas. J. Dematol. 43:175–178.

Schnitzler, P., K. Scho¨n, and J. Reichling. 2001. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie 56:343–347.

Seawright, A. 1993. Tea tree oil poisoning. Med. J. Aust. 159:831.

Shapiro, S., A. Meier, and B. Guggenheim. 1994. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol. Immunol. 9:202–208.

Shemesh, A., and W. L. Mayo. 1991. Australian tea tree oil: a natural antiseptic and fungicidal agent. Aust. J. Pharm. 72:802–803.

Sherry, E., H. Boeck, and P. H. Warnke. 2001. Topical application of a new formulation of eucalyptus oil phytochemical clears methicillin-resistant Staphylococcus aureus infection. Am. J. Infect. Control 29:346.

Shin, S. 2003. Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B. Arch. Pharma-col. Res. 26:389–393.

Sikkema, J., J. A. M. de Bont, and B. Poolman. 1995. Mechanisms of membrane toxicity of hydrocarbons. Microbiol. Rev. 59:201–222.

Soukoulis, S., and R. Hirsch. 2004. The effects of a tea tree oil-containing gel on plaque and chronic gingivitis. Aust. Dent. J. 49:78–83.

Southwell, I. A., A. J. Hayes, J. Markham, and D. N. Leach. 1993. The search for optimally bioactive Australian tea tree oil. Acta Hort. 344:256–265.

Southwell, I. A., S. Freeman, and D. Rubel. 1997. Skin irritancy of tea tree oil. J. Essent. Oil Res. 9:47–52.

Swords, G., and G. L. K. Hunter. 1978. Composition of Australian tea tree oil (Melaleuca alternifolia). J. Agric. Food Chem. 26:734–737.

Syed, T. A., Z. A. Qureshi, S. M. Ali, S. Ahmad, and S. A. Ahmad. 1999. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop. Med. Int. Health 4:284–287.

Takarada, K. 2005. The effects of essential oils on periodontopathic bacteria and oral halitosis. Oral Dis. 11:115.

Tong, M. M., P. M. Altman, and R. S. Barnetson. 1992. Tea tree oil in the
treatment of tinea pedis. Aust. J. Dermatol. 33:145–149.

Uribe, S., J. Ramirez, and A. Pen˜a. 1985. Effects of -pinene on yeast
membrane functions. J. Bacteriol. 161:1195–1200.


146a.Uribe, S., P. Rangel, G. Espı´nola, and G. Aguirre. 1990. Effects of cyclohexane, an industrial solvent, on the yeast Saccharomyces cerevisiae and on isolated yeast mitochondria. Appl. Environ. Microbiol. 56:2114–2119.

van der Valk, P. G., A. C. de Groot, D. P. Bruynzeel, P. J. Coenraads, and J. W. Weijland. 1994. Allergic contact eczema due to ‘tea tree’ oil. Ned. Tijdschr. Geneeskd. 138:823–825.

Vazquez, J. A., M. T. Arganoza, D. Boikov, J. K. Vaishampayan, and R. A. Akins. 2000. In vitro susceptibilities of Candida and Aspergillus species to Melaleuca alternifolia (tea tree) oil. Rev. Iberoam. Micol. 17:60–63.

Vazquez, J. A., and A. A. Zawawi. 2002. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin. Trials 3:379–385.

Veien, N. K., K. Rosner, and G. Skovgaard. 2004. Is tea tree oil an important contact allergen? Contact Dermatitis 50:378–379.

Viollon, C., D. Mandin, and J. P. Chaumont. 1996. Activite´s antagonistes, in vitro, de quelques huiles essentielles et de compose´s naturels volatils víš a´ vis de la croissance de Trichomonas vaginalis. Fitoterapia 67:279–281.

Walker, M. 1972. Clinical investigation of Australian Melaleuca alternifolia oil for a variety of common foot problems. Curr. Podiatry 1972:7–15.

Walsh, L. J., and J. Longstaff. 1987. The antimicrobial effects of an essential oil on selected oral pathogens. Periodontology 8:11–15.

Warnke, P. H., E. Sherry, P. A. Russo, M. Sprengel, Y. Acil, J. P. Bredee, S. Schubert, J. Wiltfang, and I. Springer. 2005. Antibacterial essential oils reduce tumor smell and inflammation in cancer patients. J. Clin. Oncol. 23:1588–1589.

Weiss, E. A. 1997. Essential oil crops. CAB International, New York, N.Y.

Williams, L. R., and V. N. Home. 1988. Plantation production of oil of melaleuca (tea tree oil)—a revitalised Australian essential oil industry. Search 19:294–297.

Williams, L. R., V. N. Home, and S. Asre. 1990. Antimicrobial activity of oil of melaleuca (tea tree oil). Its potential use in cosmetics and Toiletries. Cosmet. Aerosols Toiletries Aust. 4:12–13, 16–18,22.

Williams, L. R., V. N. Home, and I. Lusunzi. 1993. An evaluation of the
contribution of cineole and terpinen-4-ol to the overall antimicrobial activity of tea tree oil. Cosmet. Aerosols Toiletries Aust. 7:25–34